Research & Development: Page
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Paper Chase The paperless clinical trial has yet to come to fruition. According to a recent Forrester Research survey of 400 CRAs and CRCs, 97% of current data-capture practices are still done via paper, 50% are through remote data entry, 35% are through scanning/fax, 25% are Web-enabled, 22%...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
THE FORUM FOR THE INDUSTRY EXECUTIVE February 2005 www.pharmavoice.com INTEGRATING OPERATIONS Product Life-Cycle Management SEARCHING FOR ANSWERS with Peter Milner SUPPLY-CHAIN Management Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Building Consensus Dendrite hosted its Second Annual Pharmaceutical Sales and Marketing Leadership Conference in New York last October. One of the many highlights of the event was the keynote address given by President George H.W. Bush to more than 400 attendees, including heads of some of the wo...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Connecting the Dots
Ensuring trial-supply management is an integral part of overall clinical-trials management and manufacturing can bring efficiency to development and save companies time and money. Discussions about increasing efficiency and reducing time lines in clinical development often focus on patient and in...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies RxPedite Established to Provide Solutions to Emerging pharma and Biotech Companies Cardinal Health and inChord joint venture offers a full range of of launch-support services. RxPedite LLC has been established to provide comprehe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Letter From The Editor More than 40% of executives recently surveyed by Datamonitor believe their companies are failing to commit adequate time and resources to portfolio management and futhermore, 25% believe their organizations have little ability to implement and execute portfolio management e...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Prioritizing the pipeline: The role of portfolio management Increased pressures on the pharmaceutical industry ó from shrinking pipelines to rising costs, reimbursement issues, and regulatory pressures ó mean companies have to find ways to focus on the projects that will meet corpora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Year in Review Continuing regulatory scrutiny, an economy yet to rebound, and evolving world events are some of the hallmarks for 2003. As 2004 approaches, PharmaVOICE asked how the trends and challenges of 2003 have impacted your business and how these market factors...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2004 PharmaVOICE The forum for the industry executive portfolio management Strategies improving patient compliance with Dorothy Smith Device and Diagnostic Marketing www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Market Measures/Cozint Forms Emerging Markets Team Group to focus exclusively on the market research needs of emerging pharma companies. Realizing that smaller and specialized companies involved in the healthcare field have unique requireme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Pharmaceutical manufacturers spent more in 2003 on new technology in most areas and less on maintaining existing technology than other manufacturing verticals, according to AMR Research. This is to be expected as many move to packaged or Web-based applications. Investments in databases, physical ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a stu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Thomas Ebeling: A Leader on a Mission
A Leader on a Mission BY KIm Ribbink With a strong consumer background, Thomas Ebeling, CEO of Novartis Pharma AG and head of Novartis’ pharmaceuticals division worldwide, has the company positioned for growth. T homas Ebeling’s focus is to make sure Novartis is considered best in class by both d...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Oracle’s RDC to Speed Data Collection in Clinical Trials Oracle’s latest release of Clinical Remote Data Capture (RDC) features advances in usability, form design, and support for clinical trials. It provides the staff at ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCounsel
PharmaCounsel Legal Counsel: patent management When Form Equals Substance: The Value of Form Screening in Product Life-Cycle Management Pharmaceutical companies need to better manage product life cycles. companies protect their products with a variety of patents, such as composition, method of us...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Nanotechnology: It's a Small World
Nanotechnology It’s a Small World BY DENISE MYSHKO The biggest thing right now in the industry just may be the smallest. A growing interest in nanotechnology – the ability to work at the atomic and molecular levels – is spurring R&D investments in pharmaceutical discovery, diagnostics, and dr...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
WHAT’S on your mind opinions Crossing the border Lost in rhetoric The issues of assuring the integrity of the U.S. drug supply and patient safety are getting lost in the rhetoric. There needs to be a clear and credible message that the primary concern is that we can not assure the safety of impor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dear Diary: Unlocking the Patient Experience in Real Time
Dear Diary Unlocking the Patient Experience in Real Time By Denise Myshko Patient diaries As cost and implementation concerns over the use of hand-held electronic patient diaries begin to ease, companies are starting to recognize The potential for accessing patient feedback in real time. Electron...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Re:source Rabbit Enables Sales Reps to Customize and Update Marketing Materials Evatone’s Re:source Rabbit is a single-source media solution that enables customers to organize, update, and repurpose collateral, customize t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry Approval of Innovative Drugs Increase in 2003 An increase in overall drug and biologic approvals for calendar year 2003 has been reported by the Food and Drug Administration (FDA). In addition, regulatory officials...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Parents Hesitant to let Children Participate in Clinical Trials Only one in four U.S. adults would consider allowing their children to participate in clinical trials. This is one of the results of a Harris Interact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Developing a CDISC Intelligence Quotient
Developing a CDISC Intelligence Quotient Some CDISC members envision a time in the future when at least three of the CDISC standards will be combined into one. Until then, the question remains: what does CDISC-compliant mean to you? By breaking down the components of CDISC, people can better unde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Corbett Accel Healthcare Adds New Interactive Unit The new business unit, Kinect, fuses strategy with design and technology. Corbett Accel Healthcare Group has expanded its interactive offerings with the establishment of Kinect. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New Electronic and Web-based Applications, Sites, and Technologies Wolters Kluwer Launches Web Portal and Monitoring Service Wolters Kluwer Health Pharma Solutions business unit has launched the Website adisonline.info. The site is designed to inform clinicians and researchers about devel...
By PharmaVoice Team • Jan. 2, 2008
Previous
